Mosaic ImmunoEngineering, Inc. (OTCMKTS:CPMV) Short Interest Update

Mosaic ImmunoEngineering, Inc. (OTCMKTS:CPMV) saw a significant growth in short interest during the month of November. As of November 15th, there was short interest totalling 600 shares, a growth of 20.0% from the October 31st total of 500 shares. Based on an average daily volume of 400 shares, the short-interest ratio is currently 1.5 days.

Mosaic ImmunoEngineering Price Performance

Shares of CPMV opened at $1.00 on Tuesday. The business has a fifty day moving average of $0.91 and a 200 day moving average of $0.77. The company has a market cap of $7.24 million, a PE ratio of -6.67 and a beta of 0.01. Mosaic ImmunoEngineering has a 52-week low of $0.10 and a 52-week high of $1.13.

About Mosaic ImmunoEngineering

Mosaic ImmunoEngineering, Inc, a development-stage biotechnology company, focuses on developing and commercializing immunomodulator platform technology for the treatment of cancer and infectious diseases in humans and for veterinary use. Its lead immunotherapy product candidate, MIE-101, a nanoparticle-based treatment derived from cowpea mosaic virus, which is non-infectious in humans and animals.